Avidity Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $2,973 | $2,336 | $2,045 | $3,543 |
Gross Profit | 2,336 | 1,358 | 2,902 | |
EBITDA | -97,424 | -82,626 | -76,546 | |
EBIT | -98,134 | -83,313 | -77,187 | |
Net Income | -102,257 | -80,398 | -70,793 | -68,855 |
Net Change In Cash | 2,973 | 2,336 | 2,045 | 3,543 |
Free Cash Flow | -103,787 | -67,319 | -65,535 | -71,295 |
Cash | 219,868 | 370,187 | 575,751 | 471,400 |
Basic Shares | 119,893 | 123,375 | 106,928 | 87,212 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,897 | $9,560 | $9,224 | $9,326 |
Gross Profit | 10,897 | 7,459 | 9,224 | 9,326 |
EBITDA | -378,936 | -233,497 | -177,526 | -117,412 |
EBIT | -235,598 | -178,913 | -118,051 | |
Net Income | -322,302 | -212,220 | -169,077 | -117,370 |
Net Change In Cash | 10,897 | 9,560 | 9,224 | 9,326 |
Free Cash Flow | -307,936 | -123,292 | -139,091 | -98,553 |
Cash | 219,868 | 185,082 | 340,396 | 405,543 |
Basic Shares | 111,582 | 73,012 | 52,162 | 41,428 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.80 |
2024-09-30 | -$0.65 |
2024-06-30 | -$0.65 |
2024-03-31 | -$0.79 |
